Trisk Bio

Trisk Bio, located in Stevenage, UK, is a pioneering biotechnology company that has raised an $11M seed round from prominent investors in the US and UK. The company is dedicated to building a fully automated facility aimed at manufacturing biological therapies, starting with gene therapies. This innovative approach eliminates the traditional scale-up process by using robotics to parallelize production, enabling therapeutics companies to transition directly from development to market. Trisk Bio’s team comprises experts in biology, regulatory affairs, mechanical engineering, and physics. They are committed to maintaining a small, efficient team throughout the construction of their first manufacturing facility. Additionally, Trisk Bio has a proven track record, having previously collaborated on deploying mass Covid tests across the UK. The company also supports a diverse workforce by sponsoring visas and hiring globally.